09-16-2016

IRPF and the Phytochemical Society of Europe announce the creation of the IRPF-Phytochemical Society of Europe Innovation Awards

Pierre Fabre Research And Development Institute (IRPF) And the Phytochemical Society of Europe have announced the creation of the Innovation Awards and called for candidates for the 2017 Awards. A strategic approach for IRPF part of its Open Innovation strategy. Candidatures are open to scientists from all over the world and the Awards will recognize highly innovative research projects in phytochemistry and plant biochemistry in 4 core fields covered by the IRPF: Oncology, Dermatology, the Central Nervous System (CNS) and Consumer Health Care.

The applicants for the 2017 IRPF-Phytochemical Society of Europe Innovation Awards can apply until December 31st 2016 on the PSE website at http://phytochemicalsociety.org

Depending on the quality of the applications, the IRPF and the Phytochemical Society of Europe will deliver between 1 to 3 Awards of 3 000€ value each in the 4 covered therapeutic fields. The laureates will be announced in March 2017 and the Awards will be officially delivered during one of the conferences held by the Phytochemical Society of Europe in 2017. The recipients will also be invited to present their research at Pierre Fabre R&D Center located on the Toulouse Oncopole Campus.

The Pierre Fabre Research And Development Institute has already committed to the Phytochemical Society of Europe to supporting these Awards for the 3 upcoming years (2017-2019). 

Our support to the Phytochemical Society of Europe through these Awards aims at fostering innovation in phytochemistry and plant biochemistry which has always been a major expertise at Pierre Fabre R&D, stated Laurent Audoly, Pierre Fabre Pharmaceuticals R&D Director. This is an initiative that falls within the framework of our proven Open Innovation strategy as illustrated by the launch of our Nature Open Library Program (December 2015) and the Pierre Fabre Fund for Innovation (February 2016), he concluded.


Read press release